Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 13, 2025
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
ALNY
ALNYLAM PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$52.52B$397.55-3.65%$151.92M1,282.42x19.74
United States
45
ONC
BEONE MEDICINES LTD
NASDAQ
Biotechnology
A$35.34B$319.06-0.55%$318.03M6,381.20x0.85
Cayman Islands
53
NVT
NVENT ELECTRIC PLC
NYSE
Electrical Equipment & Parts
A$16.41B$101.71-6.82%$1.08B27.71x0.86
United Kingdom
42
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$13.42B$11.650.52%-$598.90M-3.77x1.49
United States
30
JAZZ
JAZZ PHARMACEUTICALS PLC
NASDAQ
Biotechnology
A$10.18B$167.501.58%$182.64M-27.96x1.87
Ireland
16
SGHC
SUPER GROUP (SGHC) LTD
NYSE
Gambling
A$5.79B$11.44-0.69%N/A22.97x0.60
Guernsey
35
MLCO
MELCO RESORTS & ENTERTAINMENT LTD
NASDAQ
Resorts & Casinos
A$3.45B$8.11-2.52%N/A30.04x-6.91
Hong Kong
30
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$3.34B$65.00-1.10%-$592.00k-76.47x1.69
United States
26
FOLD
AMICUS THERAPEUTICS INC
NASDAQ
Biotechnology
A$3.26B$10.556.57%$59.28M-263.75x2.77
United States
23
SUPN
SUPERNUS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$2.70B$47.161.40%$64.66M-142.91x0.35
United States
28
SPNT
SIRIUSPOINT LTD
NYSE
Insurance - Reinsurance
A$2.62B$22.450.76%$339.10M13.52x4.64
Bermuda
30
HCI
HCI GROUP INC
NYSE
Insurance - Property & Casualty
A$2.43B$187.472.88%$301.16M10.86x1.82
United States
52
EXTR
EXTREME NETWORKS INC
NASDAQ
Communication Equipment
A$2.26B$16.91-2.45%$65.83M241.50x15.82
United States
34
FIVN
FIVE9 INC
NASDAQ
Software - Infrastructure
A$1.65B$21.14-1.54%$127.81M50.33x1.28
United States
54
BLBD
BLUE BIRD CORP
NASDAQ
Auto Manufacturers
A$1.60B$50.36-2.18%$194.43M12.56x1.45
United States
52
NUTX
NUTEX HEALTH INC
NASDAQ
Health Information Services
A$1.31B$184.89-2.94%$227.40M8.72x1.66
United States
50
ANAB
ANAPTYSBIO INC
NASDAQ
Biotechnology
A$1.24B$44.94-1.83%-$82.14M-16.40x-13.00
United States
15
DFIN
DONNELLEY FINANCIAL SOLUTIONS INC
NYSE
Capital Markets
A$1.22B$45.86-0.84%$119.00M41.32x0.93
United States
41
CRTO
CRITEO SA
NASDAQ
Advertising Agencies
A$1.07B$20.39-1.88%$219.28M6.54x0.79
France
51
TBPH
THERAVANCE BIOPHARMA INC
NASDAQ
Biotechnology
A$920.72M$18.172.77%$55.37M31.33x0.79
Cayman Islands
37
UDMY
UDEMY INC
NASDAQ
Education & Training Services
A$768.48M$5.25-6.25%$28.86M-175.00x1.79
United States
23
BWMN
BOWMAN CONSULTING GROUP LTD
NASDAQ
Engineering & Construction
A$629.08M$36.21-0.74%$38.00M36.95x0.95
United States
53
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$611.72M$4.821.05%$18.04M-40.17x0.49
United States
20
BWMX
BETTERWARE DE MEXICO SAPI DE CV
NYSE
Specialty Retail
A$525.79M$14.09-0.28%$145.14MN/A6.80
Mexico
45
VREX
VAREX IMAGING CORP
NASDAQ
Medical Devices
A$488.31M$11.71-0.43%-$1.00M-6.89x1.31
United States
24
LE
LANDS' END INC
NASDAQ
Apparel Retail
A$472.01M$15.451.98%$86.84M41.76x2.69
United States
32
OPRX
OPTIMIZERX CORP
NASDAQ
Health Information Services
A$249.04M$13.36-4.78%$11.65MN/A0.39
United States
26
ELMD
ELECTROMED INC
NYSEMKT
Medical Devices
A$248.97M$29.851.02%$12.05M30.77x0.20
United States
54
CXDO
CREXENDO INC
NASDAQ
Telecom Services
A$212.04M$6.90-1.00%$7.94M46.00x0.24
United States
42
INFU
INFUSYSTEM HOLDINGS INC
NYSEMKT
Medical Instruments & Supplies
A$187.91M$9.240.33%$24.16M35.54x0.78
United States
45

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.